ARTICLE | Financial News
Antiva Biosciences completes venture financing
March 31, 2017 5:17 AM UTC
On March 28, HPV play Antiva Biosciences Inc. (Menlo Park, Calif.) raised $22 million in a series C round led by new investor Brace Pharma Capital. New investors NS Investment, Osage University Partn...
BCIQ Company Profiles